{"transactions":[{"id":942645,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-01-09T22:15:33.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, of which 1/4 will vest equally on 1/1/27, 1/1/28, 1/1/29, and 1/1/30."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":798111,"source":{"system":"sec-edgar","filing":"0001437749-26-001015","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926001015/rdgdoc.xml","form_type":"4"}},{"id":1291147,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-01-30T22:15:48.000Z","date":"2025-01-29","kind":"grant","planned":false,"acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, of which 1/4 will vest equally on 1/1/26, 1/1/27, 1/1/28, and 1/1/29."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":708111,"source":{"system":"sec-edgar","filing":"0001437749-25-002290","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925002290/rdgdoc.xml","form_type":"4"}},{"id":1308904,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-01-07T23:01:15.000Z","date":"2025-01-06","kind":"sale","planned":false,"acquired":false,"shares":10021,"price":28.534,"value":285939.214,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 45,000 shares on January 1, 2025, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":660611,"source":{"system":"sec-edgar","filing":"0001437749-25-000662","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925000662/rdgdoc.xml","form_type":"4"}},{"id":1308903,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-01-07T23:01:15.000Z","date":"2025-01-03","kind":"sale","planned":false,"acquired":false,"shares":11337,"price":30.294,"value":343443.078,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 45,000 shares on January 1, 2025, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":670632,"source":{"system":"sec-edgar","filing":"0001437749-25-000662","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925000662/rdgdoc.xml","form_type":"4"}},{"id":1644078,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-02-15T02:53:50.000Z","date":"2023-12-15","kind":"gift","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the transfer of shares of TG Therapeutics stock to the Power Family and Descendants Trust."}],"balance_after":641969,"source":{"system":"sec-edgar","filing":"0001437749-24-004259","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924004259/rdgdoc.xml","form_type":"5"}},{"id":1686257,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-01-05T22:00:59.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects a grant of restricted shares, of which 1/4 will vest on 1/1/2025, 1/4 will vest on 1/1/2026, 1/4 will vest on 1/1/2027, and 1/4 will vest on 1/1/2028."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":681969,"source":{"system":"sec-edgar","filing":"0001437749-24-000756","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924000756/rdgdoc.xml","form_type":"4"}},{"id":1686256,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-01-05T22:00:59.000Z","date":"2024-01-03","kind":"sale","planned":false,"acquired":false,"shares":47867,"price":16.91,"value":809430.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 95,000 shares on January 1, 2024, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":606969,"source":{"system":"sec-edgar","filing":"0001437749-24-000756","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924000756/rdgdoc.xml","form_type":"4"}},{"id":1868065,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2023-06-05T22:26:42.000Z","date":"2023-06-02","kind":"sale","planned":false,"acquired":false,"shares":73647,"price":26.7,"value":1966374.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 148,750 shares on May 31, 2023, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":654836,"source":{"system":"sec-edgar","filing":"0001104659-23-068182","document":"tm2317823-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465923068182/tm2317823-1_4seq1.xml","form_type":"4"}},{"id":1955173,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2023-03-14T21:00:47.000Z","date":"2023-03-12","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, of which 1/4 will vest on 1/1/2024, 1/4 will vest on 1/1/2025, 1/4 will vest on 1/1/2026, and 1/4 will vest on 1/1/2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":728483,"source":{"system":"sec-edgar","filing":"0001104659-23-032338","document":"tm239588-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465923032338/tm239588-2_4seq1.xml","form_type":"4"}},{"id":2203528,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-07-22T20:33:48.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects a grant of options relating to 2021 service and performance, of which 1/2 will vest on 1/1/2024 and 1/2 will vest upon U.S. Food and Drug Administration approval of ublituximab as a treatment for patients with relapsing forms of multiple sclerosis."}],"balance_after":200000,"derivative":{"exercise_price":7,"expiration_date":"2027-07-20","underlying":"Common Stock, par value $0.001","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-22-082024","document":"tm2221660-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922082024/tm2221660-6_4seq1.xml","form_type":"4"}},{"id":2203527,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-07-22T20:33:48.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, of which 1/3 will vest on 1/1/2023, 1/3 will vest upon U.S. Food and Drug Administration approval of ublituximab as a treatment for patients with relapsing forms of multiple sclerosis, and 1/3 will vest upon approval by the European Medicines Agency of ublituximab."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":643483,"source":{"system":"sec-edgar","filing":"0001104659-22-082024","document":"tm2221660-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922082024/tm2221660-6_4seq1.xml","form_type":"4"}},{"id":2440612,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2022-01-07T23:11:53.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":9653,"price":18.31,"value":176746.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 160,000 shares on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which are subject to vesting and 140,000 shares of TG Therapeutics stock issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of this filing."}],"balance_after":568483,"source":{"system":"sec-edgar","filing":"0001104659-22-002361","document":"tm222217d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922002361/tm222217d1_4.xml","form_type":"4"}},{"id":2440611,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2022-01-07T23:11:53.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":75312,"price":19.2,"value":1445990.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 160,000 shares on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."}],"balance_after":578136,"source":{"system":"sec-edgar","filing":"0001104659-22-002361","document":"tm222217d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922002361/tm222217d1_4.xml","form_type":"4"}},{"id":2659486,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2021-06-22T22:27:10.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares relating that will vest in according to the following schedule: 50% on January 1, 2022, and 25% on each of January 1, 2023 and 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which are subject to vesting and 107,500 shares of TG Therapeutics stock issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of this filing."}],"balance_after":653448,"source":{"system":"sec-edgar","filing":"0001104659-21-084262","document":"tm2120405-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465921084262/tm2120405-7_4seq1.xml","form_type":"4"}},{"id":2864386,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2021-02-12T22:01:20.000Z","date":"2020-12-21","kind":"gift","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflects the transfer of shares as a bona fide gift to a 501(c)(3) charitable organization."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 107,500 shares of TG Therapeutics stock issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of this filing."}],"balance_after":629438,"source":{"system":"sec-edgar","filing":"0001104659-21-022085","document":"tm216578d1_5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465921022085/tm216578d1_5.xml","form_type":"5"}},{"id":2864385,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2021-02-12T22:01:20.000Z","date":"2020-10-09","kind":"gift","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the transfer of shares of TG Therapeutics stock to the Power Family and Descendants Trust."}],"balance_after":636438,"source":{"system":"sec-edgar","filing":"0001104659-21-022085","document":"tm216578d1_5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465921022085/tm216578d1_5.xml","form_type":"5"}},{"id":2926281,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2021-01-04T21:30:29.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares relating to 2020 service and performance. This award will vest in approximately equal tranches on January 1, 2022, 2023, 2024 and 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which are subject to vesting."}],"balance_after":653338,"source":{"system":"sec-edgar","filing":"0001104659-21-000339","document":"tm211514d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465921000339/tm211514d1_4.xml","form_type":"4"}},{"id":3079778,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2020-07-20T23:00:17.000Z","date":"2020-07-16","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects a special long-term incentive award consisting of a grant of restricted shares that will vest in approximately equal tranches on January 1, 2021, 2022, 2023 and 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which are subject to vesting."}],"balance_after":633338,"source":{"system":"sec-edgar","filing":"0001104659-20-084949","document":"tm2025277d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/tm2025277d1_4.xml","form_type":"4"}},{"id":3079777,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2020-07-20T23:00:17.000Z","date":"2020-07-16","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares relating to 2019 service and performance. This award will vest in approximately equal tranches on January 1, 2021, 2022, 2023 and 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which are subject to vesting."}],"balance_after":433338,"source":{"system":"sec-edgar","filing":"0001104659-20-084949","document":"tm2025277d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/tm2025277d1_4.xml","form_type":"4"}},{"id":3469059,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2019-07-03T20:00:42.000Z","date":"2019-07-01","kind":"sale","acquired":false,"shares":17654,"price":8.47,"value":149529.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of 35,000 shares on June 30, 2019, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold in this transaction.  The range of prices for such transaction was $8.41 to $9.26. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted Common Stock, which are subject to vesting."}],"balance_after":383338,"source":{"system":"sec-edgar","filing":"0001654954-19-007935","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495419007935/section16.xml","form_type":"4"}},{"id":3710327,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-04T00:21:20.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest according to the following schedule: 25% on each of January 1, 2020, January 1, 2021, January 1, 2022, and January 1, 2023."}],"balance_after":115000,"derivative":{"exercise_price":4.1,"expiration_date":"2028-12-31","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001654954-19-000085","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495419000085/section16.xml","form_type":"4"}},{"id":3710326,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2019-01-04T00:21:20.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":37275,"price":4.13,"value":153945.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of 72,500 shares on January 1, 2019, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted Common Stock, which are subject to vesting."}],"balance_after":400992,"source":{"system":"sec-edgar","filing":"0001654954-19-000085","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495419000085/section16.xml","form_type":"4"}},{"id":3873168,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2018-07-05T21:00:35.000Z","date":"2018-07-03","kind":"sale","acquired":false,"shares":35000,"price":13.19,"value":461650.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":438267,"source":{"system":"sec-edgar","filing":"0001654954-18-007370","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/section16.xml","form_type":"4"}},{"id":3873167,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2018-07-05T21:00:35.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":12191,"price":13.26,"value":161652.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of 25,000 shares on June 30, 2018, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price."}],"balance_after":473267,"source":{"system":"sec-edgar","filing":"0001654954-18-007370","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/section16.xml","form_type":"4"}},{"id":4113946,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2018-01-03T22:25:45.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":32006,"price":8.5,"value":272051.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"32,006 shares were sold in connection with the vesting of 62,500 shares on January 1, 2018, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":485458,"source":{"system":"sec-edgar","filing":"0001654954-18-000068","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495418000068/section16.xml","form_type":"4"}},{"id":4113945,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2018-01-03T22:25:45.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest according to the following schedule: 25% on January 1, 2019; 25% on January 1, 2020; and 50% on the later to occur of: (a) the date that the Company's Market Capitalization is $100 million greater than the Market Capitalization on December 31, 2017 and (b) January 1, 2019."}],"balance_after":517464,"source":{"system":"sec-edgar","filing":"0001654954-18-000068","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495418000068/section16.xml","form_type":"4"}},{"id":4278005,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2017-06-19T22:05:26.000Z","date":"2017-06-19","kind":"sale","acquired":false,"shares":30000,"price":11.04,"value":331200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":447464,"source":{"system":"sec-edgar","filing":"0001654954-17-005702","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495417005702/section16.xml","form_type":"4"}},{"id":4278004,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"COMMON STOCK","published_at":"2017-06-19T22:05:26.000Z","date":"2017-06-16","kind":"sale","acquired":false,"shares":29976,"price":11.14,"value":333932.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of 58,334 shares on June 15, 2017, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price."}],"balance_after":477464,"source":{"system":"sec-edgar","filing":"0001654954-17-005702","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495417005702/section16.xml","form_type":"4"}},{"id":4504299,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"officer":true,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"Common Stock","published_at":"2017-01-04T22:28:28.000Z","date":"2017-01-04","kind":"sale","acquired":false,"shares":8816,"price":4.55,"value":40112.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the vesting of 15,000 shares on January 1, 2017, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":507440,"source":{"system":"sec-edgar","filing":"0001354488-17-000035","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000135448817000035/issuerdirect_section16.xml","form_type":"4"}},{"id":4504298,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":69714,"kind":"person","name":"Power Sean A","position":1,"cik":"0001538845","reported_name":"Power Sean A","relationship":{"officer":true,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"Common Stock","published_at":"2017-01-04T22:28:28.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest according to the following schedule: 17.5% on January 1, 2018; 17.5% on January 1, 2019; 35% on the later to occur of: (a) the date that the Company's Market Capitalization is $100 million greater than the Market Capitalization on December 31, 2016 and (b) June 30, 2019; and 30% on performance based thresholds associated with the Company?s clinical programs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":516256,"source":{"system":"sec-edgar","filing":"0001354488-17-000035","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000135448817000035/issuerdirect_section16.xml","form_type":"4"}}]}